Results 21 to 30 of about 5,575,329 (338)

Etiology model for many vaccination adverse reactions, including SARS-CoV-2 spike vaccines

AIMS Allergy and Immunology, 2022
ObjectiveVaccinated individuals (vaccinees) experience no adverse events, mild adverse events, multiple adverse events, or serious adverse events post vaccination.
Darrell O. Ricke
doaj   +1 more source

Ocular Adverse Events After COVID-19 Vaccination

Ocular immunology and inflammation, 2021
Purpose The COVID-19 pandemic has galvanized the development of new vaccines at an unprecedented pace. Since the widespread implementation of vaccination campaigns, reports of ocular adverse effects after COVID-19 vaccinations have emerged.
Xin Le Ng, B. Betzler, Ilaria Testi, S. Ho, M. Tien, W. K. Ngo, M. Zierhut, S. Chee, Vishali Gupta, C. Pavesio, M. D. de Smet, Rupesh V Agrawal   +11 more
semanticscholar   +1 more source

Gastrointestinal adverse events of immunotherapy

BJR|Open, 2021
Cancer immunotherapy with immune-checkpoint inhibitors (ICIs) has emerged as an effective treatment for different types of cancer. ICIs are monoclonal antibodies that inhibit the signaling pathway that suppress antitumor T-cell activity. Patients benefit from increased overall and progression-free survival, but the enhancement of normal immunity can ...
Cappello, Giovanni, Molea, Francesca, Campanella, Delia, Galioto, Francesca, Russo, Filippo, Regge, Daniele   +5 more
openaire   +4 more sources

Perception of the Disclosure of Adverse Events in a Latin American Culture: A National Survey [PDF]

Global Journal on Quality and Safety in Healthcare, 2022
Introduction: Adverse events are common and are responsible for a significant burden in the healthcare setting. Such issues can vary according to the local culture and relevant policies.
Thiago Gomes Romano, Joao Gabriel Rosa Ramos, Viviane Martins Almeida, Helidea de Oliveira Lima, Rodolpho Pedro   +4 more
doaj   +1 more source

Adverse events of raltegravir and dolutegravir [PDF]

AIDS, 2017
To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir.Prospective cohort study.All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who initiated raltegravir or dolutegravir between 2006 and 2015 were investigated ...
Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel   +8 more
openaire   +6 more sources

Reducing preventable adverse events in obstetrics by improving interprofessional communication skills – Results of an intervention study

BMC Pregnancy and Childbirth, 2023
Background Progress in medicine involves the structured analysis and communication of errors. Comparability between the individual disciplines is only possible to a limited extent and obstetrics plays a special role: the expectation of a self-determined ...
Beate Hüner, Christina Derksen, Martina Schmiedhofer, Sonia Lippke, Sandra Riedmüller, Wolfgang Janni, Frank Reister, Christoph Scholz   +7 more
doaj   +1 more source

Cosmetics utilization and associated adverse events: A community based cross-sectional study

Clinical Epidemiology and Global Health, 2023
Background: Cosmetics can enhance a person's perception of their beauty, but they can also be harmful. Despite a high incidence of adverse events, no study was conducted on cosmetics usage patterns and their associated adverse events at the community ...
Sweta Kumari, Biplab Pal, Devesh Tewari, Sanjeev Kumar Sahu   +3 more
doaj   +1 more source

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Journal of Clinical Oncology, 2018
Purpose To increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy.
J. Brahmer, C. Lacchetti, B. Schneider, M. Atkins, Kelly J. Brassil, J. Caterino, I. Chau, M. Ernstoff, Jennifer M. Gardner, P. Ginex, S. Hallmeyer, Jennifer Holter Chakrabarty, N. Leighl, J. Mammen, D. McDermott, A. Naing, L. Nastoupil, T. Phillips, Laura D. Porter, I. Puzanov, C. Reichner, B. Santomasso, Carole Seigel, A. Spira, M. Suarez‐Almazor, Yinghong Wang, J. Weber, J. Wolchok, John A Thompson   +28 more
semanticscholar   +1 more source

Adverse Events Reported From COVID-19 Vaccine Trials: A Systematic Review

Indian Journal of Clinical Biochemistry, 2021
COVID-19 infection originated in Wuhan, China in December 2019 and crippled human health globally in no time. The public health emergency required urgent efforts to develop and test the efficacy and safety of vaccines to combat the COVID-19 pandemic. The
Rimplejeet Kaur, S. Dutta, P. Bhardwaj, J. Charan, Sameer Dhingra, Dr Prasenjit Mitra, Kavita Singh, Dharmveer Yadav, Praveen Sharma, S. Misra   +9 more
semanticscholar   +1 more source

Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review

Vaccines, 2022
The main aim of this study is to investigate the current evidence regarding the association between COVID-19 vaccination and ocular vascular events. The protocol is registered on PROSPERO (CRD42022358133).
Hashem Abu Serhan, Abdelaziz Abdelaal, Mohammad T. Abuawwad, Mohammad J. J. Taha, Sara Irshaidat, Leen Abu Serhan, Luai Abu-Ismail, Qusai Faisal Abu Salim, Basel Abdelazeem, Ayman G. Elnahry   +9 more
doaj   +1 more source